A | Â | Â | Â | Â |
---|---|---|---|---|
Characteristics | p-value | Odds ratio | 95% CI lower | 95% CI upper |
Menopausal status | 0.176 | 0.854 | 0.177 | 1.465 |
Age at diagnosis | 0.283 | 0.916 | 0.110 | 1.906 |
ER | 0.454 | 0.809 | 0.191 | 2.233 |
HER-2 | 0.483 | 0.971 | 0.117 | 2.602 |
Triple negative status | 0.128 | 1.006 | 0.213 | 2.834 |
Tumor grading | 0.982 | 0.968 | 0.194 | 4.075 |
Lymph node (N+) | 0.644 | 0.873 | 0.125 | 3.614 |
Pathological response to primary chemotherapy | 0.043 | 5.274 | 1.388 | 26.173 |
8092A | 0.048 | 2.690 | 1.091 | 9.053 |
19007C | 0.031 | 4.177 | 1.226 | 23.131 |
B | Â | Â | Â | Â |
Characteristics | p-value | Odds ratio | 95% CI lower | 95% CI upper |
C8092 + T19007 | 0.430 | 1.266 | 0.334 | 3.231 |
8092A + 19007C | 0.049 | 4.377 | 1.031 | 23.112 |
ER | 0.332 | 0.793 | 0.143 | 2.655 |
PR | 0.459 | 1.127 | 0.178 | 4.117 |
HER-2 | 0.139 | 0.699 | 0.166 | 1.223 |
Ki67 | 0.073 | 0.222 | 0.053 | 1.081 |
Pathological response to primary chemotherapy | 0.051 | 0.565 | 0.136 | 1.377 |